To include your compound in the COVID-19 Resource Center, submit it here.

Cardium, Transdel deal

Cardium will acquire substantially all of Transdel's assets for up to $4 million in unregistered shares at a minimum of $0.50 per share.

Read the full 238 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE